BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1947439)

  • 1. Substituent effects on the binding constants of arsenical-dithiol adducts.
    Dill K; Huang LH; McGown EL; Youn SH; O'Connor RJ
    Res Commun Chem Pathol Pharmacol; 1991 Jun; 72(3):367-70. PubMed ID: 1947439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative binding constants of arsenical-antidote adducts determined by NMR spectroscopy.
    O'Connor RJ; McGown EL; Dill K; Hallowell SF
    Res Commun Chem Pathol Pharmacol; 1990 Sep; 69(3):365-8. PubMed ID: 2173085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation energies and formation rate constants for organic arsenical-antidote adducts as determined by dynamic NMR spectroscopy.
    Dill K; Huang LH; Bearden DW; McGown EL; O'Connor RJ
    Chem Res Toxicol; 1991; 4(3):295-9. PubMed ID: 1912312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semiempirical self-consistent field (CNDO) calculations of arsenical-antidote adducts.
    Bennett DW; Huang LH; Dill K
    Chem Res Toxicol; 1992; 5(1):5-7. PubMed ID: 1581536
    [No Abstract]   [Full Text] [Related]  

  • 5. Modeling the chelation of As(III) in lewisite by dithiols using density functional theory and solvent-assisted proton exchange.
    Harper LK; Bayse CA
    J Inorg Biochem; 2015 Dec; 153():60-67. PubMed ID: 26479948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Facile dimethylarsenic exchange and pyramidal inversion in its cysteine and glutathione adducts.
    Bohle DS; Gu Y
    Org Biomol Chem; 2013 Apr; 11(16):2578-81. PubMed ID: 23503635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arsenical-based affinity chromatography of vicinal dithiol-containing proteins: purification of L1210 leukemia cytoplasmic proteins and the recombinant rat c-erb A beta 1 T3 receptor.
    Kalef E; Walfish PG; Gitler C
    Anal Biochem; 1993 Aug; 212(2):325-34. PubMed ID: 8214573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2,3-Dithioerythritol, a possible new arsenic antidote.
    Boyd VL; Harbell JW; O'Connor RJ; McGown EL
    Chem Res Toxicol; 1989; 2(5):301-6. PubMed ID: 2562424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel biotinylated phenylarsonous acids as bifunctional reagents for spatially close thiols: studies on reduced antibodies and the agonist binding site of reduced Torpedo nicotinic receptors.
    Moaddel R; Sharma A; Huseni T; Jones GS; Hanson RN; Loring RH
    Bioconjug Chem; 1999; 10(4):629-37. PubMed ID: 10411461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. British anti-lewisite (BAL), the classic heavy metal antidote.
    Oehme FW
    Clin Toxicol; 1972; 5(2):215-22. PubMed ID: 4559017
    [No Abstract]   [Full Text] [Related]  

  • 11. Study on the interaction between 2-mercaptoethanol, dimercaprol and CdSe quantum dots.
    Dong F; Han H; Liang J; Lu D
    Luminescence; 2008; 23(5):321-6. PubMed ID: 18500695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The fate of arsenical vesicants in the skin and the effect of BAL (British anti-lewisite).
    Graham AF; Levvy GA; Chance AC
    Biochem J; 1947; 41(3):352-7. PubMed ID: 16748172
    [No Abstract]   [Full Text] [Related]  

  • 13. A new, stereoselective, ring-forming reaction of 1,2-ethanedithiol with N-acylated indoles.
    Tsotinis A; Eleutheriades A; Bari LD; Pescitelli G
    J Org Chem; 2007 Nov; 72(23):8928-31. PubMed ID: 17941672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. British anti-lewisite; a report on its use and therapeutic value in arsenical intoxications, from the BAL Conference, Medical Research Council.
    PETERS RA; BENNET J
    Br Med J; 1947 Oct; 2(4526):520. PubMed ID: 20267003
    [No Abstract]   [Full Text] [Related]  

  • 15. Synthesis and structural characterization of the mono- and diphosphine-containing diiron propanedithiolate complexes related to [FeFe]-hydrogenases. Biomimetic H2 evolution catalyzed by (mu-PDT)Fe2(CO)4[(Ph2P)2N(n-Pr)].
    Song LC; Li CG; Ge JH; Yang ZY; Wang HT; Zhang J; Hu QM
    J Inorg Biochem; 2008 Nov; 102(11):1973-9. PubMed ID: 18783833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The treatment of lewisite and other arsenical vesicant lesions of the eyes of rabbits with British anti-lewisite (BAL).
    MANN I; PIRIE A; PULLINGER BD
    Am J Ophthalmol; 1947 Apr; 30(4):421-35. PubMed ID: 20256316
    [No Abstract]   [Full Text] [Related]  

  • 17. Quantification of arsenic compounds using derivatization, solvent extraction and liquid chromatography electrospray ionization tandem mass spectrometry.
    Huang M; Wang YT; Ho PC
    J Pharm Biomed Anal; 2008 Dec; 48(5):1381-91. PubMed ID: 18977105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HEPATIC ALDEHYDE OXIDASE. 3. THE SUBSTRATE-BINDING SITE.
    RAJAGOPALAN KV; HANDLER P
    J Biol Chem; 1964 Jun; 239():2027-35. PubMed ID: 14213393
    [No Abstract]   [Full Text] [Related]  

  • 19. A computational study of detoxification of lewisite warfare agents by British anti-lewisite: catalytic effects of water and ammonia on reaction mechanism and kinetics.
    Sahu C; Pakhira S; Sen K; Das AK
    J Phys Chem A; 2013 Apr; 117(16):3496-506. PubMed ID: 23540856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. British anti-Lewisite (dimercaprol): an amazing history.
    Vilensky JA; Redman K
    Ann Emerg Med; 2003 Mar; 41(3):378-83. PubMed ID: 12605205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.